Literature DB >> 6229477

HLA class I specific T lymphocyte clones with dual alloreactive functions.

N Flomenberg, C Russo, S Ferrone, B Dupont.   

Abstract

Four human T lymphocyte clones exhibiting proliferative responses to class I HLA antigens were isolated from an in vitro mixed lymphocyte culture (MLC). Three clones expressed the Leu-2+3- phenotype and demonstrated proliferation in response to HLA-B8, while the fourth clone expressed the Leu-2-3+ phenotype and proliferated in response to HLA-A2. These clones were also cytotoxic towards cells bearing the same target antigens. Blocking studies utilizing monoclonal antibodies demonstrated that proliferation was triggered by determinants on the class I molecule itself, and these determinants appear to be spatially close to those which determine serologic allospecificity. These findings support the concept that the class I molecules themselves are the weak MLC stimulating determinants previously mapped to the HLA-A and B regions of the major histocompatibility complex.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6229477     DOI: 10.1007/bf00364474

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  40 in total

1.  T-cell lines which cooperate in generation of specific cytolytic activity.

Authors:  A L Glasebrook; F W Fitch
Journal:  Nature       Date:  1979-03-08       Impact factor: 49.962

2.  Primed LD typing (PLT)-technical considerations.

Authors:  M J Sheehy; F H Bach
Journal:  Tissue Antigens       Date:  1976-09

3.  Three closely linked genetic systems relevant to transplantation.

Authors:  E J Yunis; D B Amos
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

4.  [Position of a locus determining mixed lymphocyte reaction distinct from the known HL-A loci].

Authors:  V P Eijsvoogel; J J van Rood; E D Du Toit; P T Schellekens
Journal:  Eur J Immunol       Date:  1972-10       Impact factor: 5.532

Review 5.  Cloning and characterization of primary alloreactive human T-lymphocytes.

Authors:  J Kornbluth; D M Silver; B Dupont
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

Review 6.  Studies Utilizing murine T cell clones: Ir genes, Ia antigens and MLR stimulating determinants.

Authors:  C G Fathman; M Kimoto
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

7.  Primed lymphocyte testing specificity of alloreactive lymphocyte clones for HLA-B locus determinants.

Authors:  A Zeevi; C Scheffel; K Annen; R J Duquesnoy
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

8.  Autonomously proliferating K/D-restricted cytolytic T cell clones.

Authors:  H Von Boehmer; K Turton
Journal:  Eur J Immunol       Date:  1983-02       Impact factor: 5.532

9.  Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse.

Authors:  F H Bach; M B Widmer; M L Bach; J Klein
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

10.  Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines.

Authors:  A L Glasebrook; F W Fitch
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307

View more
  3 in total

1.  Lymphocyte transformation induced by autologous cells. XVI: Distinctive role of discrete regions of class I MHC antigens in the autologous mixed leucocyte reaction.

Authors:  J B Innes; F C Garbrecht; M E Weksler; C Russo
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

2.  Major histocompatibility complex class I-restricted alloreactive CD4+ T cells.

Authors:  Louise H Boyle; Jane C Goodall; J S Hill Gaston
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

3.  Alloreactive T Cell Receptor Diversity against Structurally Similar or Dissimilar HLA-DP Antigens Assessed by Deep Sequencing.

Authors:  Esteban Arrieta-Bolaños; Pietro Crivello; Maximilian Metzing; Thuja Meurer; Müberra Ahci; Julie Rytlewski; Marissa Vignali; Erik Yusko; Peter van Balen; Peter A Horn; J H Frederik Falkenburg; Katharina Fleischhauer
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.